CIC
HALO icon

Cornercap Investment Counsel’s Halozyme HALO Stock Holding History

Cornercap Investment Counsel’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,007
Closed -$383K – 280
2024
Q4 		$383K Hold
8,007
– – 0.12% 289
2024
Q3 		$458K Sell
8,007
-20,204
-72% -$1.16M 0.14% 278
2024
Q2 		$1.48M Sell
28,211
-232
-0.8% -$10.2K 0.24% 111
2024
Q1 		$1.16M Buy
28,443
+358
+1% +$13.4K 0.18% 184
2023
Q4 		$1.04M Buy
28,085
+15,924
+131% +$600K 0.17% 236
2023
Q3 		$465K Sell
12,161
-43
-0.4% -$1.76K 0.08% 420
2023
Q2 		$440K Buy
12,204
+1,399
+13% +$47.7K 0.08% 435
2023
Q1 		$413K Buy
+10,805
New +$507K 0.07% 441

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cornercap Investment Counsel's HALO Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Halozyme (HALO) in Q1 2025, closing a stake of 8,007 shares — an estimated $383K sold.

Cornercap Investment Counsel first reported a position in HALO in Q1 2023 and held it in 8 quarters. The position peaked at $1.48M in Q2 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 8,007 Halozyme shares in Q1 2025, an estimated $383K.
  • Cornercap Investment Counsel first reported a position in Halozyme in Q1 2023 and held it in 8 quarters.
  • Cornercap Investment Counsel's Halozyme position peaked at $1.48M in Q2 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.